(Q41676828)

6 October 2017

1 reference

title

Influenza vaccines. A reappraisal of their use. (English)

1 reference

6 October 2017

Palache AM

1

1 reference

6 October 2017

publication date

1 December 1997

1 reference

6 October 2017

1 reference

6 October 2017

volume

54

1 reference

6 October 2017

issue

6

1 reference

6 October 2017

page(s)

841-856

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-199754060-00004

6 October 2017

exact match

0 references

cites work

Adverse reactions to influenza vaccine in elderly people: randomised double blind placebo controlled trial

1 reference

12 December 2020

Influenza and pneumococcal vaccination of the elderly: newer vaccines and prospects for clinical benefits at the margin

1 reference

12 December 2020

Safety and immunogenicity of a cold-adapted influenza A (H1N1) reassortant virus vaccine administered to infants less than six months of age.

1 reference

12 December 2020

Trivalent attenuated cold-adapted influenza virus vaccine: reduced viral shedding and serum antibody responses in susceptible adults

1 reference

12 December 2020

Review of cost-benefit analyses of influenza vaccine

1 reference

12 December 2020

Rhinovirus and influenza type A infections as precipitants of asthma

1 reference

12 December 2020

Influenza vaccine and pneumonia mortality in a nursing home population.

1 reference

12 December 2020

Influenza: its control in persons and populations

1 reference

12 December 2020

1 reference

12 December 2020

Introduction to oral immunization against viral infections

1 reference

12 December 2020

Socioeconomics of influenza and influenza vaccination in Europe

1 reference

12 December 2020

The effect of whole virus influenza vaccination on theophylline pharmacokinetics

1 reference

12 December 2020

DNA vaccines: a novel approach to immunization.

1 reference

12 December 2020

Association between rise in antibodies and increase in airway sensitivity after intramuscular injection of killed influenza virus in asthmatic patients

1 reference

12 December 2020

Nasal application of inactivated influenza vaccine

1 reference

12 December 2020

Enhancement of the protective efficacy of inactivated influenza A virus vaccine in aged mice by IL-2 liposomes

1 reference

12 December 2020

Bronchial responsiveness and leucocyte reactivity after influenza vaccine in asthmatic patients.

1 reference

12 December 2020

Effects of influenza virus vaccine on hepatic drug metabolism

1 reference

12 December 2020

Safety of influenza vaccination in adults with asthma

1 reference

12 December 2020

Recombinant vaccinia virus expressing the PR/8 influenza hemagglutinin gene overcomes the impaired immune response and increased susceptibility of old mice to influenza infection

1 reference

12 December 2020

The iscom antigen-presenting system

1 reference

12 December 2020

Community pharmacists as immunization advocates. Cost-effectiveness of a cue to influenza vaccination.

1 reference

12 December 2020

Inactivated influenza vaccines. 2. Laboratory indices of protection

1 reference

12 December 2020

Age-dependent antibody response in mice and humans following oral influenza immunization

1 reference

12 December 2020

Assessment of inactivated influenza-A vaccine after three outbreaks of influenza A at Christ's Hospital

1 reference

12 December 2020

Influenza in the elderly: report of an outbreak and a review of vaccine effectiveness reports

1 reference

12 December 2020

Failure of influenza vaccination in the aged

1 reference

12 December 2020

Phase 1 clinical tests of influenza MDP-virosome vaccine (KD-5382).

1 reference

12 December 2020

Liposomes, lipid A, and aluminum hydroxide enhance the immune response to a synthetic malaria sporozoite antigen

1 reference

12 December 2020

Guillain-Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976--1977

1 reference

12 December 2020

Influenza vaccination in asthma

1 reference

12 December 2020

Immunopotentiation of local and systemic humoral immune responses by ISCOMs, liposomes and FCA: role in protection against influenza A in mice

1 reference

12 December 2020

Biodegradable microparticles for oral immunization.

1 reference

12 December 2020

Liposomes enhance the immunogenicity of reconstituted influenza virus A/PR/8 envelopes and the formation of protective antibody by influenza virus A/Sichuan/87 (H3N2) surface antigen

1 reference

12 December 2020

Effectiveness of cholera toxin B subunit as an adjuvant for nasal influenza vaccination despite pre-existing immunity to CTB

1 reference

12 December 2020

Cost-effectiveness analysis of antigrippal vaccination in a rural population (La Victoria, Cordoba)

1 reference

12 December 2020

Disparity between influenza vaccination rates and risks for influenza-associated hospital discharge and death in Manitoba in 1982-1983

1 reference

12 December 2020

A randomized controlled trial of influenza vaccine in the elderly. Scientific scrutiny and ethical responsibility.

1 reference

12 December 2020

Evaluation of the infectivity, immunogenicity, and efficacy of live cold-adapted influenza B/Ann Arbor/1/86 reassortant virus vaccine in adult volunteers

1 reference

12 December 2020

Immunity to influenza in man

1 reference

12 December 2020

Safety of Influenza Vaccination in Allergic Children

1 reference

12 December 2020

Effect of influenza vaccine in patients receiving long-term warfarin therapy

1 reference

12 December 2020

Cytotoxic T lymphocyte memory: role in cross-protective immunity against influenza?

1 reference

12 December 2020

Impact of Medicare reimbursement on influenza vaccination rates in the elderly.

1 reference

12 December 2020

Influenza: a serious epidemic disease that can be prevented

1 reference

12 December 2020

Increased anti-influenza A virus cytotoxic T cell activity following vaccination of the chronically ill elderly with live attenuated or inactivated influenza virus vaccine

1 reference

12 December 2020

Re: "Guillain-Barré syndrome and influenza vaccination in the US Army, 1980-1988"

1 reference

12 December 2020

Purified influenza A virus N2 neuraminidase vaccine is immunogenic and non-toxic in humans

1 reference

12 December 2020

Enhancement of protective antibody responses by cholera toxin B subunit inoculated intranasally with influenza vaccine

1 reference

12 December 2020

Effects of killed and live attenuated influenza vaccine on symptoms and specific airway conductance in asthmatics and healthy subjects

1 reference

12 December 2020

Lack of clinical exacerbations in adults with chronic asthma after immunization with killed influenza virus

1 reference

12 December 2020

No effect of influenza vaccination on theophylline pharmacokinetics as studied by ultraviolet spectrophotometry, HPLC, and EMIT assay methods

1 reference

12 December 2020

Effects of vaccination on an influenza epidemic in a geriatric hospital

1 reference

12 December 2020

Enhancement of humoral response against human influenza vaccine with the simple submicron oil/water emulsion adjuvant MF59.

1 reference

12 December 2020

Lack of effect of highly purified subunit influenza vaccination on theophylline metabolism

1 reference

12 December 2020

Comparative trial of large-particle aerosol and nose drop administration of live attenuated influenza vaccines

1 reference

12 December 2020

Clinical effectiveness of influenza vaccination in Manitoba

1 reference

12 December 2020

Mortality and influenza

1 reference

12 December 2020

Economic aspects of vaccination

1 reference

12 December 2020

Experimental polyvalent ISCOMs subunit vaccine induces antibodies that neutralize human and bovine respiratory syncytial virus

1 reference

12 December 2020

Influenza prevention--the key to reduction in morbidity and mortality from acute respiratory disease (ARD)

1 reference

12 December 2020

The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial

1 reference

12 December 2020

What do we not know? What work is required?

1 reference

12 December 2020

Adjuvant activities of synthetic lipid A subunit analogues and its conjugates with muramyl dipeptide derivatives

1 reference

12 December 2020

Cholera toxin and cholera B subunit as oral-mucosal adjuvant and antigen vector systems

1 reference

12 December 2020

The costs and benefits of preventing influenza in Ontario's elderly

1 reference

12 December 2020

Potential of polymer microencapsulation technology for vaccine innovation

1 reference

12 December 2020

Purified influenza virus hemagglutinin and neuraminidase are equivalent in stimulation of antibody response but induce contrasting types of immunity to infection

1 reference

12 December 2020

Effective immunization with live attenuated influenza A virus can be achieved in early infancy. Pediatric Care Center

1 reference

12 December 2020

Systemic and local antibody responses in elderly subjects given live or inactivated influenza A virus vaccines

1 reference

12 December 2020

Adjuvants--a balance between toxicity and adjuvanticity

1 reference

12 December 2020

The effects of influenza virus infection on FEV1 in asthmatic children. The time-course study

1 reference

12 December 2020

Oral delivery of vaccines. Formulation and clinical pharmacokinetic considerations

1 reference

12 December 2020

Influenza vaccination in 18 developed countries, 1980-1992.

1 reference

12 December 2020

Antiviral immunity induced by recombinant nucleoprotein of influenza A virus. I. Characteristics and cross-reactivity of T cell responses

1 reference

12 December 2020

Pharmacokinetic Drug Interactions with Theophylline

1 reference

12 December 2020

Immunomodulation of influenza virus infection in the precipitating asthma attack

1 reference

12 December 2020

Preparation and characterization of a purified influenza virus neuraminidase vaccine

1 reference

12 December 2020

Influenza vaccine effectiveness in preventing hospitalization for pneumonia in the elderly

1 reference

12 December 2020

Comparison of intranasal and aerosol infection of mice in assessment of immunity to influenza virus infection

1 reference

12 December 2020

Subunit vaccines against enveloped viruses: virosomes, micelles and other protein complexes

1 reference

12 December 2020

Influenza and pneumococcal vaccination in Canada and the United States, 1980-1993: what can the two countries learn from each other?

1 reference

12 December 2020

Influenza vaccination and theophylline pharmacokinetics in patients with chronic obstructive lung disease

1 reference

12 December 2020

Controlled trial of inactivated influenza vaccine containing the a-Hong Kong strain during an outbreak of influenza due to the a-England-42-72 strain

1 reference

12 December 2020

Infectious agents associated with exacerbations of chronic obstructive bronchopneumopathies and asthma attacks

1 reference

12 December 2020

Preclinical efficacy of a prototype DNA vaccine: Enhanced protection against antigenic drift in influenza virus

1 reference

12 December 2020

Immune responses to influenza virus in orally and systemically immunized mice

1 reference

12 December 2020

Immunogenicity of new virosome influenza vaccine in elderly people

1 reference

12 December 2020

Adjuvant action of cholera toxin and pertussis toxin in the induction of IgA antibody response to orally administered antigen.

1 reference

12 December 2020

Effect of influenza vaccine on warfarin anticoagulation

1 reference

12 December 2020

Enhancement of antibody responses to influenza B virus haemagglutinin by use of a new adjuvant formulation

1 reference

12 December 2020

Viruses as precipitants of asthmatic attacks in children

1 reference

12 December 2020

Benefits and costs of vaccination

1 reference

12 December 2020

Reduction in mortality associated with influenza vaccine during 1989-90 epidemic.

1 reference

12 December 2020

The systemic and mucosal immune response of humans to influenza A virus

1 reference

12 December 2020

The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community.

1 reference

12 December 2020

Cell culture as a substrate for the production of influenza vaccines: memorandum from a WHO meeting

1 reference

12 December 2020

Gender differences in local and systemic reactions to inactivated influenza vaccine, established by a meta-analysis of fourteen independent studies

1 reference

12 December 2020

Immunogenicity of liposomes and iscoms containing the major outer membrane protein of Neisseria gonorrhoeae: influence of protein content and liposomal bilayer composition

1 reference

12 December 2020

Antibody response to a foreign epitope expressed at the surface of recombinant bacteria: importance of the route of immunization

1 reference

12 December 2020

Acute respiratory disease associated with influenza epidemics in Houston, 1981-1983.

1 reference

12 December 2020

Influenza vaccination in Australia: a review of the economic evidence for policy recommendations.

1 reference

12 December 2020

Cytotoxic T lymphocytes specific for influenza virus.

1 reference

12 December 2020

Influenza at Christ's Hospital: March, 1974.

1 reference

12 December 2020

An epidemiologic and clinical evaluation of Guillain-Barré syndrome reported in association with the administration of swine influenza vaccines

1 reference

12 December 2020

Recombinant secreted haemagglutinin protects mice against a lethal challenge of influenza virus

1 reference

12 December 2020

Study of the effectiveness of influenza vaccination in the elderly in the epidemic of 1989-90 using a general practice database

1 reference

12 December 2020

Controlled release microparticles for vaccine development

1 reference

12 December 2020

Efficacy of sequential annual vaccination with inactivated influenza virus vaccine

1 reference

12 December 2020

Viral respiratory tract infection and exacerbations of asthma in adult patients

1 reference

12 December 2020

Impact of epidemic type A influenza in a defined adult population

1 reference

12 December 2020

New strategies for using mucosal vaccination to achieve more effective immunization

1 reference

12 December 2020

Benefits, risks and costs of viral vaccines

1 reference

12 December 2020

Biodegradable microspheres as a vaccine delivery system

1 reference

12 December 2020

Recommendations of the 7th European Meeting of Influenza and Its Prevention

1 reference

12 December 2020

Safety of Intramuscular Influenza Immunization Among Patients Receiving Long-term Warfarin Anticoagulation Therapy

1 reference

12 December 2020

Safety of the subunit influenza vaccine in asthmatic children

1 reference

12 December 2020

Does influenza immunisation cause exacerbations of chronic airflow obstruction or asthma?

1 reference

12 December 2020

What to expect of a good vaccine and how to achieve it.

1 reference

12 December 2020

Oral immunization with influenza virus: experimental and clinical studies

1 reference

12 December 2020

Immunogenicity and reactogenicity of influenza subunit vaccines produced in MDCK cells or fertilized chicken eggs

1 reference

12 December 2020

Summary of Clinical Trials of Inactivated Influenza Vaccine--1978

1 reference

12 December 2020

Antiviral and adjuvant activity of immunomodulator adamantylamide dipeptide

1 reference

12 December 2020

Effect of Influenza Vaccine on Chronic Warfarin Therapy

1 reference

12 December 2020

Influenza immunization status and viral respiratory tract infections in patients with chronic airflow limitation

1 reference

12 December 2020

Readiness is all: public health experts draft plan outlining pandemic influenza response

1 reference

12 December 2020

Protective efficacy of combined live intranasal and inactivated influenza A virus vaccines in the elderly

1 reference

12 December 2020

Increased response of asthmatic subjects to methacholine after influenza vaccine

1 reference

12 December 2020

Mucosal immunoadjuvant activity of liposomes: induction of systemic IgG and secretory IgA responses in mice by intranasal immunization with an influenza subunit vaccine and coadministered liposomes

1 reference

12 December 2020

Subunit influenza vaccination in adults with asthma: effect on clinical state, airway reactivity, and antibody response

1 reference

12 December 2020

Frequency of adverse reactions to influenza vaccine in the elderly. A randomized, placebo-controlled trial

1 reference

12 December 2020

Failure to respond to influenza vaccine in the aged: correlation with B-cell number and function

1 reference

12 December 2020

Determinants of immunity to influenza infection in man

1 reference

12 December 2020

Lack of effect of influenza and pneumococcal vaccines on anticoagulation by warfarin

1 reference

12 December 2020

Guillain-Barré syndrome in the United States, 1979-1980 and 1980-1981. Lack of an association with influenza vaccination

1 reference

12 December 2020

Dose response of A/Alaska/6/77 (H3N2) cold-adapted reassortant vaccine virus in adult volunteers: role of local antibody in resistance to infection with vaccine virus

1 reference

12 December 2020

Influenza virus ISCOMs: antibody response in animals

1 reference

12 December 2020

Secretory antibody following oral influenza immunization

1 reference

12 December 2020

Cold recombinant influenza B/Texas/1/84 vaccine virus (CRB 87): attenuation, immunogenicity, and efficacy against homotypic challenge

1 reference

12 December 2020

Guillain-Barré syndrome and influenza vaccination in the US Army, 1980-1988.

1 reference

12 December 2020

Effect of immunomodulator thymopentin on impaired seroresponse to influenza vaccine in patients on haemodialysis

1 reference

12 December 2020

Efficacy of influenza vaccine in nursing homes. Reduction in illness and complications during an influenza A (H3N2) epidemic

1 reference

12 December 2020

Decreased elimination of theophylline after influenza vaccination.

1 reference

12 December 2020

Prevention and control of influenza: Part I, Vaccines. Recommendations of the Advisory Committee on Immunization Practices (ACIP)

1 reference

12 December 2020

Final results: Medicare influenza vaccine demonstration--selected states, 1988-1992

1 reference

12 December 2020

Immune response to immunostimulatory complexes (ISCOMs) prepared from human immunodeficiency virus type 1 (HIV-1) or the HIV-1 external envelope glycoprotein (gp120).

1 reference

12 December 2020

Influenza immunization policies in Europe and the United States

1 reference

12 December 2020

Immunization with Killed Influenza Virus in Children with Chronic Asthma

1 reference

12 December 2020

1 reference

12 December 2020

Effect of influenza vaccines in stimulating antibody in volunteers with prior immunity

1 reference

12 December 2020

Influenza vaccination. Knowledge, attitudes, and behavior among high-risk outpatients

1 reference

12 December 2020

Reassessment of the Association between Guillain-Barré Syndrome and Receipt of Swine Influenza Vaccine in 1976–1977: Results of a Two-State Study

1 reference

12 December 2020

Guillain-Barré Syndrome and the 1978–1979 Influenza Vaccine

1 reference

12 December 2020

The clinical efficacy of influenza vaccination

1 reference

12 December 2020

Theophylline clearance. Lack of effect of influenza vaccination and ascorbic acid

1 reference

12 December 2020

French economic evaluations of influenza and influenza vaccination

1 reference

12 December 2020

Immunogenicity and efficacy of orally administered inactivated influenza virus vaccine in mice

1 reference

12 December 2020

Pilot evaluation of influenza virus vaccine (IVV) combined with adjuvant

1 reference

12 December 2020

Influenza vaccination of elderly persons. Reduction in pneumonia and influenza hospitalizations and deaths

1 reference

12 December 2020

Respiratory viruses and exacerbations of asthma in adults

1 reference

12 December 2020

Comparison of Serology and Reactogenicity between Influenza Subunit Vaccines and Whole Virus or Split Vaccines: A Review and Meta-Analysis of the Literature

1 reference

12 December 2020

Immunogenicity of influenza A virus N2 neuraminidase produced in insect larvae by baculovirus recombinants

1 reference

12 December 2020

Influenza vaccination in asthma

1 reference

12 December 2020

Anti-influenza vaccination for active persons (25-64 years): a cost-benefit study

1 reference

12 December 2020

Monovalent Influenza A/New Jersey/76 Virus Vaccines in Asthmatic Children: Pulmonary Function and Skin Tests for Allergy

1 reference

12 December 2020

Selective induction of protection against influenza virus infection in mice by a lipid-peptide conjugate delivered in liposomes

1 reference

12 December 2020

Escherichia coli heat-labile enterotoxin B subunits supplemented with a trace amount of the holotoxin as an adjuvant for nasal influenza vaccine.

1 reference

12 December 2020

Acute respiratory illness in the community. Frequency of illness and the agents involved

1 reference

12 December 2020

Safe administration of influenza vaccine in asthmatic children hypersensitive to egg proteins

1 reference

12 December 2020

Characterization and Immunological Properties of Influenza A Virus Nucleoprotein (NP): Cell-associated NP Isolated from Infected Cells or Viral NP Expressed by Vaccinia Recombinant Virus do not Confer Protection

1 reference

12 December 2020

Multicenter Two-Dose Trials of Bivalent Influenza A Vaccines in Asthmatic Children Aged Six to 18 Years

1 reference

12 December 2020

Activation of systemic and mucosal immune response following nasal administration of liposomes

1 reference

12 December 2020

Recurrent wheezy bronchitis and viral respiratory infections

1 reference

12 December 2020

Serum theophylline levels after influenza vaccination.

1 reference

12 December 2020

Morbidity associated with the major respiratory viruses

1 reference

12 December 2020

Efficacy of inactivated influenza vaccine delivered by oral administration

1 reference

12 December 2020

Intranasal immunization with proteoliposomes protects against influenza

1 reference

12 December 2020

Lack of effect of influenza vaccine on warfarin anticoagulation in the elderly

1 reference

12 December 2020

Effectiveness and cost-benefit of an influenza vaccination program for health care workers

1 reference

12 December 2020

Evaluating new vaccines for developing countries. Efficacy or effectiveness?

1 reference

12 December 2020

The immune response to influenza infection

1 reference

12 December 2020

The common mucosal immune system and current strategies for induction of immune responses in external secretions

1 reference

12 December 2020

Factors affecting the use of influenza vaccine in the institutionalized elderly.

1 reference

12 December 2020

Immunopotentiating reconstituted influenza virosomes (IRIVs) and other adjuvants for improved presentation of small antigens

1 reference

12 December 2020

Impact of influenza on mortality in relation to age and underlying disease, 1967-1989.

1 reference

12 December 2020

Circulating cellular immune response to oral immunization of humans with cholera toxin B-subunit

1 reference

12 December 2020

Association of influenza immunization with reduction in mortality in an elderly population. A prospective study

1 reference

12 December 2020

Sense and nonsense of influenza vaccination in asthma and chronic obstructive pulmonary disease

1 reference

12 December 2020

Infection-permissive immunization with influenza virus neuraminidase prevents weight loss in infected mice

1 reference

12 December 2020

Antibody response after influenza immunization with various vaccine doses: a double-blind, placebo-controlled, multi-centre, dose-response study in elderly nursing-home residents and young volunteers

1 reference

12 December 2020

Current progress in the development of the B subunits of cholera toxin and Escherichia coli heat-labile enterotoxin as carriers for the oral delivery of heterologous antigens and epitopes

1 reference

12 December 2020

The efficacy of influenza vaccine in elderly persons. A meta-analysis and review of the literature.

1 reference

12 December 2020

Harnessing cytotoxic T lymphocytes for vaccine design

1 reference

12 December 2020

Drug interactions involving immunologic agents. Part I. Vaccine-vaccine, vaccine-immunoglobulin, and vaccine-drug interactions

1 reference

12 December 2020

Oral immunization with influenza virus in biodegradable microspheres

1 reference

12 December 2020

10.2165/00003495-199754060-00004

Identifiers

DOI

1 reference

Dimensions Publication ID

6 October 2017

1050619111

0 references

1 reference